Analysis Of Income And Expense [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Analysis of income and expense [abstract] | ||||||||||
| Revenue [abstract] | ||||||||||
| Revenue |
297,200,000
USD
|
— | — | — | — | — |
245,316,000
USD
|
— | — | — |
| Material income and expense [abstract] | ||||||||||
| Research and development expense |
83,147,000
USD
|
— | — | — | — | — |
68,914,000
USD
|
— | — | — |
| Finance income (cost) |
1,889,000
USD
|
— | — | — | — | — |
6,336,000
USD
|
— | — | — |
| Sales and marketing expense |
118,802,000
USD
|
— | — | — | — | — |
124,049,000
USD
|
— | — | — |
| Miscellaneous other comprehensive income [abstract] | ||||||||||
| Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract] | ||||||||||
| Other comprehensive income, net of tax, exchange differences on translation of foreign operations |
11,980,000
USD
|
— | — | — | — | — |
5,936,000
USD
|
— | — | — |
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||||||||||
| Share of profit (loss) of associates accounted for using equity method |
1,760,000
USD
|
— | — | — | — | — |
289,000
USD
|
— | — | — |
| Comprehensive income, continuing and discontinued operations [abstract] | ||||||||||
| Comprehensive income |
23,742,000
USD
|
—
USD
|
—
USD
|
10,346,000
USD
|
13,396,000
USD
|
—
USD
|
3,445,000
USD
|
10,548,000
USD
|
—
USD
|
7,103,000
USD
|